Request An Appointment
patient portal
online payments
Order Contacts Online

iStent

iStent® Trabecular Micro-Bypass

Technology has always played an important role in eye care. Today, almost every aspect of vision is connected to a product or procedure that wasn’t available even ten short years ago. The cataract surgery you are scheduled for is a good example of how innovations can make a difference. Every aspect of it utilizes recently developed technology that will help us improve your vision. Today, this includes managing your mild-to-moderate open-angle glaucoma: because now we are able to add another step to your cataract surgery that allows you to treat your open-angle glaucoma in a completely new way. This is important because once diagnosed, you and most patients like you will spend the rest of your lives putting one, two or even three different kinds of drops in every day. Unfortunately, all of these drops will not only be inconvenient, but potentially very expensive. The iStent Trabecular Micro-Bypass Stent is designed to reduce your eye pressure and you can have it done at the same time you have cataract surgery.

iStent: the world’s smallest medical implant delivers big results in mild-to-moderate open-angle glaucoma.

While mild-to-moderate open-angle glaucoma is very common, many people are unaware of their condition, especially in the early stages, when their vision may be unaffected. In many people, open-angle glaucoma is characterized by an increase in the intraocular pressure (IOP) of your eye. This pressure is caused by the buildup of fluid within the eye. Too much fluid raises pressure, which can cause the gradual loss of vision. And while glaucoma moves slowly, its damage is irreparable.

The world’s tiniest medical device—iStent—is 20,000 times smaller than the intraocular lenses (IOL) used in your cataract surgery. But the size of iStent is only part of its story. By increasing the eye’s ability to drain fluid, this technology is designed to reduce the pressure in your eye.

In a U.S. clinical study, 68% of glaucoma patients who received iStent remained medication free at 12 months while sustaining a target IOP of ≤ 21 mm Hg vs. only 50% of patients who underwent cataract surgery alone.

istent Pennsylvania

Our Locations

Altoona Office

176 Vision Drive
Duncansville, PA 16635

814.949.8808

Bedford Office

Keystone North Professional Building
3759 Business 220, Suite 010
Bedford, PA 15522

814.623.0088

Brookville Office

50 Waterford Pike
Brookville, PA 15825

814.849.8344

Clearfield Office

235 East Market Street
Clearfield, PA 16830

814.765.6963

DuBois Office

472 Jeffers St.
DuBois, PA 15801

814.371.6143

St. Marys Office

Canadensis Building
241 Depot Street
St. Marys, PA 15857

814.834.7000

Grove City Office

217 South Broad Street
Grove City, PA 16127

724.458.4840

Johnstown Office

1415 Eisenhower Blvd.
Johnstown, PA 15904

814.266.1616

New Bethlehem Office

363 Broad Street, Suite 4
New Bethlehem, PA 16242

814.275.2030

Seneca Office

2968 State Route 257 North
Seneca, PA 16346

814.676.1651